Literature DB >> 12586555

A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells.

Susana Alvarez Losada1, Carmen Cantó-Nogués, Ma Angeles Muñoz-Fernández.   

Abstract

To study the mechanism by which HIV-1 infects neurons we have used human neuroblastoma cell lines (NB). NB (SK-N-SH and SK-N-MC) were found to be susceptible to productive infection by X4 or R5 HIV-1, as detected by viral load and Ag-p24. To identify the putative receptor, we tested the cell surface expression of previously described receptors such as CD4, nucleolin, galactosylceramide, and CCR1, CCR5, and CXCR4 by cytometry and RT-PCR. NB express no CD4 and low levels of galactosylceramide or nucleolin. Furthermore, antibodies to any of these molecules did not affect NB infection. NB express variable levels of CCR5, CCR1, and CXCR4. Interestingly, exogenous heparan sulfate alone was able to substantially inhibit HIV-1 infection, an effect which was potentiated by RANTES or SDF-1 in the HIV-1-infection with R5 or X4 isolates. Besides, anti-CCR5 and anti-CXCR4 significantly blocked HIV-1 infection of R5 and X4 isolates. Our results suggest that HIV-1 entry involves a chemokine-receptor-dependent but CD4-independent entry in neural cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12586555     DOI: 10.1006/nbdi.2002.0566

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

Review 1.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

2.  HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children.

Authors:  Carmen Cantó-Nogués; Silvia Sánchez-Ramón; Susana Alvarez; César Lacruz; Ma Angeles Muñóz-Fernández
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Cell surface nucleolin facilitates enterovirus 71 binding and infection.

Authors:  Pei-Yi Su; Ya-Fang Wang; Sheng-Wen Huang; Yu-Chih Lo; Ya-Hui Wang; Shang-Rung Wu; Dar-Bin Shieh; Shun-Hua Chen; Jen-Ren Wang; Ming-Der Lai; Chuan-Fa Chang
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

4.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

Review 5.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

6.  The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.

Authors:  Elodie Crublet; Jean-Pierre Andrieu; Romain R Vivès; Hugues Lortat-Jacob
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

7.  Lack of association of HIV-1 biological or molecular properties with neurotropism for brain cells.

Authors:  Susana Alvarez; José Luis Jiménez; M Jesús Serramía; Milagros González; Carmen Cantó-Nogués; M Angeles Muñoz-Fernández
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 2.866

8.  Extracellular vesicles regulate gap junction-mediated intercellular communication and HIV-1 infection of human neural progenitor cells.

Authors:  Hyung Joon Cho; Martina Velichkovska; Nicolette Schurhoff; Ibolya E András; Michal Toborek
Journal:  Neurobiol Dis       Date:  2021-05-05       Impact factor: 7.046

Review 9.  Apoptosis of uninfected cells induced by HIV envelope glycoproteins.

Authors:  Barbara Ahr; Véronique Robert-Hebmann; Christian Devaux; Martine Biard-Piechaczyk
Journal:  Retrovirology       Date:  2004-06-23       Impact factor: 4.602

10.  DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.

Authors:  Upal Roy; Venkata S R Atluri; Marisela Agudelo; Adriana Yndart; Zaohua Huang; Madhavan Nair
Journal:  Front Microbiol       Date:  2015-07-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.